Hypothesis for risk of death or serious sequela from asthmatic use of magnesium throat lozenges due to 8- to 310-fold rhinovirus release increase by concentrated magnesium.
Eby
George
G
D001249:Asthma / Q000188:drug therapy* / Q000401:mortality* / Q000517:prevention & control*; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008274:Magnesium / Q000494:pharmacology; D015636:Magnesium Chloride / Q000008:administration & dosage / Q000627:therapeutic use*; D008954:Models, Biological; D008962:Models, Theoretical; D009055:Mouth / Q000503:physiopathology / Q000821:virology*; D010614:Pharynx / Q000503:physiopathology; D012229:Rhinovirus / Q000378:metabolism*; D012306:Risk; D013607:Tablets
D013607:Tablets; D015636:Magnesium Chloride; D008274:Magnesium